RELAPSED B-CELL NHL

Clinical trials for RELAPSED B-CELL NHL explained in plain language.

Never miss a new study

Get alerted when new RELAPSED B-CELL NHL trials appear

Sign up with your email to follow new studies for RELAPSED B-CELL NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for hard-to-treat lymphoma: experimental drug enters human testing

Disease control Ongoing

This early-stage study tests a new oral drug, JNJ-88998377, in about 58 people with relapsed or refractory B-cell non-Hodgkin's lymphoma (a type of blood cancer). The main goals are to check the drug's safety and find the best dose for future studies. Participants must have measu…

Matched conditions: RELAPSED B-CELL NHL

Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

RELAPSED B-CELL NHL

Get alerted when new RELAPSED B-CELL NHL trials appear

New hope for hard-to-treat lymphoma: experimental drug enters human testing